New Stock Ratings and Share Price Targets October 28th Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Education Mgmt (NASDAQ:EDMC): Wunderlich reiterated its rating ... |
